Current controversies on the role of lymphadenectomy for testicular cancer for the journal: Urologic Oncology: Seminars and Original Investigations for the special seminars section on the role of lymphadenectomy for urologic cancers.

  • PubMed
  • May 4, 2025
  • 0 Comments

Current controversies on the role of lymphadenectomy for testicular cancer for the journal: Urologic Oncology: Seminars and Original Investigations for the special seminars section on the role of lymphadenectomy for urologic cancers.

Autor: Masterson, Timothy A.; Cary, Clint; Foster, Richard S.

Publication year: 2021

Urologic oncology

issn:1873-2496 1078-1439

doi: 10.1016/j.urolonc.2018.12.021


Abstract:

The role of surgery in the locoregional management of many solid tumors has long been established. For testicular cancer, the incorporation of lymphadenectomy has played an important part in generating long-term survival outcomes in excess of 90% for germ cell tumor patients. In this review, we address several clinical scenarios in which lymphadenectomy at times is underutilized, and others ill advised.

Language: eng

Rights: Copyright © 2018 Elsevier Inc. All rights reserved.

Pmid: 30630731

Tags: Humans; Male; Treatment Outcome; Biomedical Research/*methods; Testicular cancer; Congresses as Topic/*standards; Germ cell tumor; Lymph Node Excision/*methods; Retroperitoneal lymph node dissection; RPLND; Seminoma; Testicular Neoplasms/pathology/*surgery

Link: https://pubmed.ncbi.nlm.nih.gov/30630731/

  • Related Posts

    Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial

    Health Technol Assess. 2025 May;29(12):1-118. doi: 10.3310/YQVF5347. ABSTRACT BACKGROUND: Lithium and several atypical antipsychotics are the recommended first-line augmentation options for treatment-resistant depression; however, few studies have compared them directly,…

    Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial

    Health Technol Assess. 2025 May;29(12):1-118. doi: 10.3310/YQVF5347. ABSTRACT BACKGROUND: Lithium and several atypical antipsychotics are the recommended first-line augmentation options for treatment-resistant depression; however, few studies have compared them directly,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    • May 10, 2025
    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    • May 10, 2025
    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    • May 10, 2025
    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    • May 10, 2025
    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    • May 10, 2025
    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    How Microwaves Actually Work: A Scientific Breakdown

    • May 10, 2025
    How Microwaves Actually Work: A Scientific Breakdown